All Type of News
Foreign drug companies puzzled over short shelf life drugs.
A lot of drugs with short shelf lives gave a mounting business burden in the distribution to the retail pharmacies, especially for the expensive drugs supplied by foreign multinational drug corporations in Korea.
...
Kyungdong to register U.S. patent for famciclovir production.
Kyungdong Pharmaceutical company announced that a patent for the production process of famciclovir was completed to register in the United States, under the title of "Manufacturing method of 9-［4-acetyoxy-3-(acetoxyme...
22% increase of NHI payment for cancer patients in 2004.
The total NHI (national health insurance) payment in 2004 for the cancer patients showed about 22% increases over the previous year at 991,500 million won according to the NHIC report on Feb. 16
The same NHI paymen...
Lyplinol enjoying after NSAIDs side effect report.
A functional health food product for arthritis named Lyplinol has emerged with a rising popularity in the market after the recent KFDA's announcement of the NSAID side effects.
Lyplinol was encapsulated with active...
New policy of Zuellig for returned stocks.
Zuellig's policy of the returned goods seems to be modified, probably stemming from the frictions between drug wholesalers and KPA, a pharmacist group.
According to Annex 3 of Zuellig's new distribution agreement (...
Samjin to file patent of new therapeutic compound for C hepatitis.
Samjin has filed the patent registration to the Patent Office for a new pyrimidinedione derivative developed by Central Research Institute as an anti-viral agent, having an anti-viral activity against C hepatitis viru...
KERI to advocate prescription written in generic names.
The Korea Economic Research Institute (KERI) reported in a study paper titled "A study on the regulation reforms to strengthen the competitiveness of medical service supply system" authored by Prof. Kwon Soon-man that...
LG Life Science to apply human growth hormone for FDA approval.
LG Life Science announced on Feb. 15 that the company applied the U. S. FDA approval for Valtropin, a human growth hormone developed by the LG bio technology.
The company said "The FDA registration dossier submitt...
Janssen Korea to launch one-a-day drug for incontinence of urine.
Janssen Korea has launched Lyrinel (oxybutynine), a one-a-day dosed therapy for the incontinence of urine, by using the OROS technology, a sustained releasing drug delivery system.
The indication included the incon...
Hyundai reporting growth of sales and net profits.
Hyundai reported the 2005 business performances in the 42nd general shareholder's meeting on Feb. 13 at 101,100 million won of sales, 8,800 million won of operating incomes, 6,200 million won of net profits and 700 wo...
